Indivior Pharmaceuticals (INDV) Inventory Average (2022 - 2026)

Indivior Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $152.5 million for Q1 2026.

• In Q1 2026, Inventory Average fell 7.58% year-over-year to $152.5 million; the TTM figure through Mar 2026 stood at $152.5 million (down 7.58% YoY), while the FY2025 annual figure was $160.0 million, up 9.22% from the prior year.
• Inventory Average was $152.5 million for Q1 2026 at Indivior Pharmaceuticals, down from $154.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $165.0 million in Q1 2025 to a low of $104.5 million in Q4 2022.
• Historically, Inventory Average has averaged $143.4 million across 4 years, with a median of $152.5 million in 2026.
• The sharpest annual moves came in 2023 and 2026: Inventory Average climbed 14.83% in 2023, then dropped 7.58% in 2026.
• A 4-year view of Inventory Average shows it stood at $104.5 million in 2022, then gained by 14.83% to $120.0 million in 2023, then climbed by 28.33% to $154.0 million in 2025, then declined by 0.97% to $152.5 million in 2026.
• The last three Inventory Average figures came in at $152.5 million (Q1 2026), $154.0 million (Q4 2025), and $152.0 million (Q3 2025), per Business Quant data.